DelhiVery plans to use funds from upcoming IPO for acquisitions
时间:2024-06-17 06:07:42 阅读(143)
By Devbrat Roy Chaudhary
Logistics firm DelhiVery plans to offer its customers integrated, end-to-end services with the aid of its cutting-edge technology, Sandeep Barasia, ED and chief business officer, said.
He said that the company’s operating system makes it stand out as a logistics player and he expects that the company would become profitable as it grows its operations.
“We are primarily a technology and data science company, which is also into logistics,” added Barasia.
Kapil Bharati, co-founder and chief technology officer of the company, pointed out that the company was making use of a technology stack which had been built in-house for its operations. “We have built 80-odd applications which are being used by different stakeholders. We are also looking to export the technology to other countries, having already done a pilot project in Sri Lanka,” Bharati said.
With its 120+ gateways, 20+ automated sort centres, 80+ fulfilment centres and 2,200 direct delivery centres, the company has covered 90% of the country, operating over 15 million sq ft of leased infrastructure at a pan-India level. It provides supply chain solutions to a diverse base of 21,342 active customers, such as e-commerce marketplaces, D2C e-tailers, and enterprises and SMEs across verticals like FMCG, consumer durables, liftstyle, retail, automotive and manufacturing.
(Travel for this story was sponsored by DelhiVery)
猜你喜欢
- Ahmedabad International Kite Festival 2024- Peru’s Unique Contribution and Cultural Showcase
- Rakesh Jhunjhunwala, wife sell Delta Corp shares, trim holdings; stock tanks 20% this month
- Rakesh Jhunjhunwala stock- Brokerages bullish on Federal Bank stock, see 32% potential rally
- Emerging Contours of US FED November Policy
- Are security fears slowing down GenAI adoption-
- Adani Transmission, Adani Green Energy among 120 BSE stocks to touch 52-week lows, 112 stocks hit 52-week highs
- Raksha Bandhan 2023- Rakhi celebration begins across the nation – See images
- Expiring Pfizer covid drug doses to cost Europe $2
- Alkem Laboratories posts buoyant growth in Q2; Should you buy, hold or sell the stock-